| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P50 | author | Xingshun Qi | Q41419168 |
| P2093 | author name string | Chunping Su | |
| Xiaozhong Guo | |||
| Hongyu Li | |||
| Diya Wang | |||
| P2860 | cites work | Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis | Q95383378 |
| [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria] | Q95497453 | ||
| Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization-A Meta-Analysis | Q26866311 | ||
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
| Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study | Q33937557 | ||
| Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus | Q34647662 | ||
| Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified? | Q34719112 | ||
| Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization | Q34847211 | ||
| Find duplicates among the PubMed, EMBASE, and Cochrane Library Databases in systematic review | Q34972450 | ||
| Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials. | Q35028949 | ||
| Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? | Q36193809 | ||
| Role of surgical resection for multiple hepatocellular carcinomas | Q36561656 | ||
| Design and endpoints of clinical trials in hepatocellular carcinoma. | Q37162908 | ||
| Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation | Q37716429 | ||
| Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting. | Q38187434 | ||
| Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients. | Q39443494 | ||
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. | Q41633380 | ||
| Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. | Q42243517 | ||
| Outcome of patients with hepatitis C virus-related single, small hepatocellular carcinoma. | Q42981759 | ||
| Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. | Q43466382 | ||
| Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. | Q43576585 | ||
| Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact | Q43708819 | ||
| The role of hepatic resection in the treatment of hepatocellular cancer | Q43752461 | ||
| Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre | Q43925378 | ||
| Indications for hepatectomy for hepatocellular carcinoma - what stage of the disease is the best indication for surgery? | Q43949865 | ||
| Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver. | Q43955242 | ||
| Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience | Q44090273 | ||
| Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center | Q44250058 | ||
| Liver resection improves the survival of patients with multiple hepatocellular carcinomas | Q44264077 | ||
| Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular carcinoma - comparison to transcatheter arterial chemoembolization | Q44909510 | ||
| Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India | Q45328614 | ||
| Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C. | Q45332198 | ||
| Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area | Q45400758 | ||
| Advanced age is not a contraindication for liver resection in cases of large hepatocellular carcinoma | Q46483728 | ||
| Hepatocellular carcinoma with tumor thrombi in the portal vein. A comparison of therapeutic effects by different treatments | Q46537041 | ||
| Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation | Q46964114 | ||
| Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. | Q50876461 | ||
| BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. | Q51063349 | ||
| Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? | Q51703108 | ||
| Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis. | Q53141717 | ||
| [Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching]. | Q53144581 | ||
| Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. | Q53475196 | ||
| Comparison of transarterial chemoembolization and hepatic resection for large solitary hepatocellular carcinoma: a propensity score analysis. | Q53561450 | ||
| Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis | Q56777584 | ||
| Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis | Q58576456 | ||
| Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma | Q59203691 | ||
| Treatment and prognostic factors in patients with hepatocellular carcinoma | Q59660608 | ||
| [Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma] | Q73219781 | ||
| Role of transarterial chemoembolization before liver resection for hepatocarcinoma | Q74296484 | ||
| Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients | Q77763288 | ||
| Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study | Q81485247 | ||
| Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? | Q82845317 | ||
| Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus | Q83498126 | ||
| Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT | Q87481895 | ||
| Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching | Q87957502 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| hepatocellular carcinoma | Q1148337 | ||
| systematic review | Q1504425 | ||
| hepatectomy | Q1514021 | ||
| liver neoplasm | Q18558073 | ||
| therapeutic chemoembolization | Q68572802 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 18715-18733 | |
| P577 | publication date | 2015-07-01 | |
| 2015-07-30 | |||
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis | |
| P478 | volume | 6 |
| Q38430715 | A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma. |
| Q36301895 | Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis |
| Q42593698 | Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma |
| Q55347907 | Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study. |
| Q28072742 | Controversies and evidence of hepatic resection for hepatocellular carcinoma |
| Q30240056 | Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials |
| Q36305703 | Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials |
| Q38979703 | Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma |
| Q92840469 | Down-regulation of MiR-365 as a novel indicator to assess the progression and metastasis of hepatocellular carcinoma |
| Q40164088 | GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma |
| Q52671427 | Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients. |
| Q35801456 | Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis |
| Q88069009 | Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies |
| Q58715363 | Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma |
| Q90729197 | Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma |
| Q47155638 | Liver resection versus transplantation for multiple hepatocellular carcinoma: a propensity score analysis |
| Q37709406 | Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma |
| Q52589118 | Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30). |
| Q36668116 | Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models |
| Q37251634 | Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients |
| Q99552850 | Multimodality imaging-guided local injection of eccentric magnetic microcapsules with electromagnetically controlled drug release |
| Q36052780 | Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies |
| Q37641616 | Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. |
| Q33597359 | Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameter |
| Q89073757 | Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection |
| Q58789048 | Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child-Pugh A liver function: A double-center study from China |
| Q53300584 | The STORM trial and beyond: narrowing the horizon of adjuvant sorafenib for postoperative hepatocellular carcinoma. |
| Q33623086 | The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation |
| Q48565229 | Thermal ablation of hepatocellular carcinoma in patients with abnormal coagulation function |
| Q64085297 | Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy |
| Q33566921 | Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study |
Search more.